[1]
“A Prospective, Randomized, Interventional Study Comparing Treatment Modalities for Diffuse Diabetic Macular Oedema: Bevacizumab and Bevacizumab Combined with Macular Grid - A Prospective Single Centre Study”, mfm, vol. 28, no. 2, May 2024, Accessed: Nov. 17, 2025. [Online]. Available: https://medicalforummonthly.com/index.php/mfm/article/view/3829